Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Long acting methylphenidate
DRUG
2 trials
Sponsors
BRC Operations Pty. Ltd.
, University of California, Los Angeles
Conditions
Attention Deficit/Hyperactivity Disorder
HIV Dementia
Phase 3
A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV
NCT01599975
University of California, Los Angeles
HIV Dementia
Start: 2012-05-31
End: 2014-09-30
Target: 40
Updated: 2012-05-16
Phase 4
International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder
NCT00863499
BRC Operations Pty. Ltd.
Attention Deficit/Hyperactivity Disorder
Start: 2009-10-31
End: 2019-12-31
Target: 1344
Updated: 2018-07-11
Related Papers
Attention-Deficit/Hyperactivity Disorder Subtypes Defined by Cognition Have a Distinct Neural and Clinical Profile and Differ in Response to Atomoxetine.
2025-07-16
Electroencephalographic biomarkers as predictors of methylphenidate response in attention-deficit/hyperactivity disorder.
2018-06-22
41 citations